TennesseeSB 2149114th General Assembly (2025-2026)Senate

AN ACT to amend Tennessee Code Annotated, Title 9; Title 33; Title 53; Title 63 and Title 68, relative to clinical trials.

Sponsored By: Sponsor information unavailable

Signed by Governor

Mental Health & Substance Abuse Services, Dept. of

Personalized for You

How does this bill affect your finances?

Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Free to download

Bill Overview

Analyzed Economic Effects

4 provisions identified: 3 benefits, 1 costs, 0 mixed.

Doctor oversight and safety in trials

Ibogaine is given only at a hospital or qualified research site. A Tennessee-licensed physician must direct your care. Trials must use patient screening and safety rules that follow federal law and guidance.

Legal protection in ibogaine trials

If you are in a federally authorized ibogaine trial, Tennessee does not treat allowed trial activities as crimes. This covers providers, researchers, patients, and institutions. Protection applies only to conduct inside the trial that federal law authorizes and follows this chapter.

Tennessee institutions can run ibogaine trials

Tennessee research hospitals and universities can join ibogaine clinical trials. Trials must follow state and federal law, including a valid FDA IND when required. Institutions can use federal, private, or philanthropic money to run these trials.

Ibogaine use limited to trials

You can get ibogaine in Tennessee only if you are in an authorized clinical trial. Routine or non-research use is not allowed. The trial must follow state and federal law.

Sponsors & Cosponsors

Cosponsors

Rusty Crowe
Republican • Senate
Ferrell Haile
Republican • Senate
Bobby Harshbarger
Republican • Senate
Stevens
Affiliation unavailable

Roll Call Votes

All Roll Calls

Yes: 214 • No: 3

Senate vote • 4/23/2026

FLOOR VOTE: Motion to Concur House Amendment # 3 4/23/2026

Yes: 28 • No: 0

House vote • 4/22/2026

FLOOR VOTE: REGULAR CALENDAR AS AMENDED PASSAGE ON THIRD CONSIDERATION 4/22/2026

Yes: 84 • No: 1

Senate vote • 4/15/2026

FLOOR VOTE: as Amended Third Consideration 4/15/2026

Yes: 31 • No: 1

Senate vote • 4/15/2026

FLOOR VOTE: as Amended Third Consideration 4/15/2026

Yes: 31 • No: 1

Senate vote • 3/31/2026

SENATE FINANCE, WAYS AND MEANS COMMITTEE

Yes: 11 • No: 0

Senate vote • 3/31/2026

SENATE FINANCE, WAYS AND MEANS COMMITTEE

Yes: 11 • No: 0

Senate vote • 3/4/2026

SENATE HEALTH AND WELFARE COMMITTEE

Yes: 9 • No: 0